Format

Send to:

Choose Destination
See comment in PubMed Commons below
Methods Mol Biol. 2011;698:279-94. doi: 10.1007/978-1-60761-999-4_21.

Use of human mesenchymal stem cells as alternative source of smooth muscle cells in vessel engineering.

Author information

  • 1Department of Anesthesia & Biomedical Engineering, Yale University School of Medicine, New Haven, CT, USA.

Abstract

Adult stem cell-derived smooth muscle cells (SMC) may be a promising source of cells for applications in regenerative medicine, including cardiovascular tissue engineering. Primary SMC from native vessels may have limited proliferative capacity and reduced collagen production when sourced from elderly donors, who are the patients in need of vascular grafts due to coronary disease or peripheral arterial disease. Our recent work showed that the ability of human bone marrow-derived mesenchymal stem cells (hMSCs) to differentiate into SMC was modulated by various growth factors, matrix proteins, and mechanical forces. In addition, the components of the culture medium play a very important role in SMC differentiation from hMSCs. In this chapter, we will summarize our experience with the impact of various factors on SMC differentiation from hMSCs. Based upon our findings regarding growth factors, cyclic strain and matrix proteins, a two-phase vessel regeneration culture protocol including a 4-week proliferation phase and a 4-week differentiation phase was developed to optimize proliferation and SMC differentiation of hMSCs consecutively.

PMID:
21431526
[PubMed - indexed for MEDLINE]
PMCID:
PMC3151526
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Write to the Help Desk